Knee Osteoarthritis (Knee OA)PainDeviceDrug
What this study is
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
What's being tested
- genicular artery embolization
Intervention · DEVICE
genicular artery embolization
- Corticosteroid Injection
Intervention · DRUG
Corticosteroid Injection
Study details
- Official title
- Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit
- Sponsor
- North American Science Associates Ltd.
- Conditions
- Knee Osteoarthritis (Knee OA)
- Enrolling
- 126 people
- Starts
- 2025-10-01
- Est. completion
- 2026-12
- Design
- Open-label, randomized, crossover
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 40 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient has localized knee pain
- Must be an appropriate candidate for arterial vascular access procedure
You can't join if
- Known sensitivity or allergy to implant materials
- Unable or unwilling to comply with study requirements
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of Virginia
Charlottesville, Virginia, United States
Recruiting
Study team
Sponsor
North American Science Associates Ltd.
Study ID US037031
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.